Voce Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Voce Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-146,982	Closed	-$2.23M	–	11
2018 Q4	$2.23M	Sell	146,982 -21,616	-13%	-$412K	1.55%	8
2018 Q3	$3.37M	Sell	168,598 -15,250	-8%	-$347K	6.25%	5
2018 Q2	$3.58M	Buy	183,848 +1,726	+0.9%	+$38.2K	5.75%	5
2018 Q1	$3.67M	Buy	182,122 +24,976	+16%	+$422K	6.32%	6
2017 Q4	$2.08M	Buy	157,146 +46,357	+42%	+$699K	3.36%	7
2017 Q3	$2.04M	Buy	110,789 +16,680	+18%	+$311K	2.72%	12
2017 Q2	$1.73M	Buy	+94,109	New	+$1.86M	3.74%	11

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Voce Capital Management's AMAG Position: Q1 2019 in Review

Voce Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 146,982 shares — an estimated $2.23M sold.

Voce Capital Management first reported a position in AMAG in Q2 2017 and held it in 7 quarters. The position peaked at $3.67M in Q1 2018. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

Voce Capital Management reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Voce Capital Management sold 146,982 AMAG Pharmaceuticals shares in Q1 2019, an estimated $2.23M.
Voce Capital Management first reported a position in AMAG Pharmaceuticals in Q2 2017 and held it in 7 quarters.
Voce Capital Management's AMAG Pharmaceuticals position peaked at $3.67M in Q1 2018.
166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on Voce Capital Management's 13F filing for Q1 2019, filed 15 May 2019.